{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:10:48Z","timestamp":1762146648899,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.yexcr.2005.04.005","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T16:43:56Z","timestamp":1115397836000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Distinct I\u03baB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells"],"prefix":"10.1016","volume":"308","author":[{"given":"Hideyasu","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2005.04.005_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib2","first-page":"317","article-title":"Adult T-cell leukemia: further clinical observations and cytogenic and functional studies of leukemic cells","volume":"9","author":"Takahashi","year":"1979","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib3","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2005.04.005_bib4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2005.04.005_bib5","first-page":"893","article-title":"Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus","volume":"73","author":"Tajima","year":"1982","journal-title":"Gann"},{"key":"10.1016\/j.yexcr.2005.04.005_bib6","first-page":"2360","article-title":"Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib7","first-page":"3915","article-title":"Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells","volume":"95","author":"Mori","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-kappaB activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-472X(02)00777-4","article-title":"NF-kappaB-dependent signaling pathways","volume":"30","author":"Li","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1023733231406","article-title":"Deregulation of NF-kappaB and its upstream kinases in cancer","volume":"22","author":"Sun","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.yexcr.2005.04.005_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02982601","article-title":"Hodgkin's lymphoma and CD30 signal transduction","volume":"77","author":"Horie","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev."},{"key":"10.1016\/j.yexcr.2005.04.005_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappaB and rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81064-8","article-title":"Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity","volume":"84","author":"Chen","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2005.04.005_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/41493","article-title":"A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB","volume":"388","author":"DiDonato","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2005.04.005_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.278.5339.860","article-title":"IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation","volume":"278","author":"Mercurio","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2005.04.005_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0092-8674(00)80406-7","article-title":"The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation","volume":"91","author":"Zandi","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2005.04.005_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0092-8674(00)81466-X","article-title":"Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation","volume":"93","author":"Yamaoka","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2005.04.005_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/26261","article-title":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex","volume":"395","author":"Rothwarf","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2005.04.005_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1084\/jem.193.5.631","article-title":"Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I","volume":"193","author":"Matsushima","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2005.04.005_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-5793(02)03622-0","article-title":"Lymphotoxin-beta receptor mediates NEMO-independent NF-kappaB activation","volume":"532","author":"Saitoh","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2005.04.005_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","article-title":"The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways","volume":"17","author":"Dejardin","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2005.04.005_bib23","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.1074\/jbc.M210768200","article-title":"Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways","volume":"278","author":"Muller","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2005.04.005_bib24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni842","article-title":"BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells","volume":"3","author":"Claudio","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1074-7613(02)00425-9","article-title":"BAFF\/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2","volume":"17","author":"Kayagaki","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2005.04.005_bib26","doi-asserted-by":"crossref","first-page":"36005","DOI":"10.1074\/jbc.M304266200","article-title":"TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation","volume":"278","author":"Saitoh","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2005.04.005_bib27","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1093\/emboj\/cdf542","article-title":"CD40 regulates the processing of NF-kappaB2 p100 to p52","volume":"21","author":"Coope","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2005.04.005_bib28","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1093\/emboj\/20.23.6805","article-title":"Retroviral oncoprotein Tax induces processing of NF-kappaB2\/p100 in T cells: evidence for the involvement of IKKalpha","volume":"20","author":"Xiao","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2005.04.005_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1593\/neo.03388","article-title":"Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells","volume":"6","author":"Hironaka","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.yexcr.2005.04.005_bib30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1084\/jem.162.6.2169","article-title":"Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement","volume":"162","author":"Maeda","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2005.04.005_bib31","first-page":"155","article-title":"A novel T-cell line derived from adult T-cell leukemia","volume":"71","author":"Miyoshi","year":"1980","journal-title":"Gann"},{"key":"10.1016\/j.yexcr.2005.04.005_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.2910340213","article-title":"Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus","volume":"34","author":"Sugamura","year":"1984","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2005.04.005_bib33","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2005.04.005_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","article-title":"Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells","volume":"294","author":"Miyoshi","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2005.04.005_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/blood.V64.2.482.482","article-title":"Characterization of a novel HTLV-infected cell line","volume":"64","author":"Koeffler","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1099\/0022-1317-68-2-499","article-title":"Expression of a provirus of human T cell leukaemia virus type I by DNA transfection","volume":"68","author":"Mori","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0014-5793(02)03618-9","article-title":"A recessive mutant cell line with a constitutive IkappaB kinase activity","volume":"531","author":"Chinanonwait","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2005.04.005_bib38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0092-8674(90)90275-J","article-title":"The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product","volume":"62","author":"Kieran","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2005.04.005_bib39","doi-asserted-by":"crossref","first-page":"36062","DOI":"10.1074\/jbc.M007204200","article-title":"Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase","volume":"275","author":"Kapahi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2005.04.005_bib40","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-kappa B activation","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.yexcr.2005.04.005_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2005.04.005_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","article-title":"Nuclear factor-kappaB: the enemy within","volume":"6","author":"Aggarwal","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2005.04.005_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1023733231406","article-title":"Deregulation of NF-kappaB and its upstream kinases in cancer","volume":"22","author":"Sun","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.yexcr.2005.04.005_bib45","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1074\/jbc.M409477200","article-title":"Inhibition of I\u03baB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo","volume":"280","author":"Syrovets","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2005.04.005_bib46","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/sj.onc.1207705","article-title":"Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation","volume":"23","author":"Broemer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2005.04.005_bib47","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2005.04.005_bib48","first-page":"4901","article-title":"Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.04.005_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1242\/jcs.115.1.141","article-title":"The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells","volume":"115","author":"Gasparian","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2005.04.005_bib50","first-page":"3810","article-title":"Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer","volume":"61","author":"Romieu-Mourez","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.04.005_bib51","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/sj.leu.2402641","article-title":"Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts","volume":"16","author":"Baumgartner","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2005.04.005_bib52","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/10428190310001657326","article-title":"Constitutive NF-kappab\/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)","volume":"45","author":"Munzert","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexcr.2005.04.005_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3835(01)00611-5","article-title":"Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells","volume":"171","author":"Tamatani","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2005.04.005_bib54","first-page":"4526","article-title":"Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation","volume":"61","author":"Ludwig","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.04.005_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0301-472X(03)00069-9","article-title":"Mechanisms of Bcr-Abl-mediated NF-kappaB\/Rel activation","volume":"31","author":"Kirchner","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib56","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.onc.1208296","article-title":"The AKT\/I kappa B kinase pathway promotes angiogenic\/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin","volume":"24","author":"Agarwal","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2005.04.005_bib57","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/jvi.65.12.6892-6899.1991","article-title":"Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation","volume":"65","author":"Arima","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib58","first-page":"867","article-title":"Related articles, links abstract. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene","volume":"8","author":"Crenon","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2005.04.005_bib59","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/viro.1994.1586","article-title":"Subcellular redistribution of HTLV-1 Tax protein by NF-kappa B\/Rel transcription factors","volume":"204","author":"Pepin","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.yexcr.2005.04.005_bib60","first-page":"841","article-title":"Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway","volume":"9","author":"Lanoix","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2005.04.005_bib61","first-page":"1419","article-title":"Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma","volume":"7","author":"Sunwoo","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2005.04.005_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/msy.2001.116672","article-title":"Nuclear factor-kappa B is upregulated in colorectal cancer","volume":"130","author":"Lind","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.yexcr.2005.04.005_bib63","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2141.2001.03102.x","article-title":"Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis","volume":"115","author":"Ni","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.65.2.342","article-title":"Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells","volume":"65","author":"Nemeth","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib67","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood-2002-01-0151","article-title":"Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells","volume":"100","author":"Mori","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib68","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/JVI.78.9.4582-4590.2004","article-title":"Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells","volume":"78","author":"Mori","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib69","doi-asserted-by":"crossref","first-page":"26243","DOI":"10.1074\/jbc.M403286200","article-title":"Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation","volume":"279","author":"Liao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2005.04.005_bib70","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1084\/jem.183.5.2185","article-title":"The human OX40\/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells","volume":"183","author":"Imura","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2005.04.005_bib71","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V89.8.2951","article-title":"OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration","volume":"89","author":"Imura","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02982796","article-title":"OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis","volume":"76","author":"Kunitomi","year":"2002","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib73","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V89.8.2951","article-title":"OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration","volume":"89","author":"Imura","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2559.1995.tb00272.x","article-title":"CD30 (Ki-1) expression in adult T-cell leukaemia\/lymphoma is associated with distinctive immunohistological and clinical characteristics","volume":"26","author":"Takeshita","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.yexcr.2005.04.005_bib75","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib76","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib77","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/bbrc.2000.3651","article-title":"Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro","volume":"277","author":"Ora","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2005.04.005_bib78","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1015272401822","article-title":"Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects","volume":"73","author":"Baj","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.yexcr.2005.04.005_bib79","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-291X(02)02831-0","article-title":"Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis","volume":"300","author":"Park","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2005.04.005_bib80","first-page":"3065","article-title":"Arsenic trioxide-mediated growth inhibition in MC\/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.04.005_bib81","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1523-1747.2003.12479.x","article-title":"Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C)","volume":"121","author":"Michel","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yexcr.2005.04.005_bib82","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1182\/blood-2002-04-1154","article-title":"Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis","volume":"102","author":"Mathas","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.04.005_bib83","first-page":"7950","article-title":"Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells","volume":"63","author":"Nimmanapalli","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.04.005_bib84","doi-asserted-by":"crossref","first-page":"22747","DOI":"10.1074\/jbc.M314131200","article-title":"Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway","volume":"279","author":"Ivanov","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482705001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482705001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:05:06Z","timestamp":1762146306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482705001643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0014482705001643"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2005.04.005","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct I\u03baB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2005.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}